Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
TRYBE
United Kingdom
- London, England
- 13/01/2026
- Series A
- $30,000,000
Spa, leisure, and hospitality management doesn't need to be complicated. TRYBE is your cloud-native all-in-one booking solution to help you modernise and level up your business operations.
Designed by the industry, for the industry, our system integrates seamlessly with your existing software leading to greater efficiency for your team and a greater experience for your guests.
Why TRYBE?
-Increase your revenue
-Access TRYBE from any device, anywhere
-Automate sales and inventory management
-Use your team's live availability to take bookings online
-Deliver a seamless payment experience for customers
-Receive instant reporting and analytics
-Grow your database
- Collect intake forms ahead of guest arrival
And so much more!
Send us a message and we can tell you more about the power of TRYBE.
- Industry Software Development
- Website https://try.be/us/
- LinkedIn https://www.linkedin.com/company/trybe-software/
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)